Lexie Lumen vs Otofonix Groove

The Lexie Lumen is a budget-priced OTC hearing aid that earned a B grade with a SoundScore of 3.5/5 in our lab testing, placing it in the top 60% of the OTC category. At $299, this behind-the-ear device uses disposable batteries and represents one of the more affordable entry points into amplification. In our standardized testing, the Lumen demonstrated notably strong feedback handling, scoring 5.0/5 in the tuned configuration—0.46 points above the category average. This excellent stability means users can expect minimal whistling during typical daily activities. Speech in noise performance scored 2.0/5, which is above the category average by 0.55 points, though still mixed in absolute terms. The device shows clear limitations in certain areas. Music streaming scored 0.0/5, falling 1.92 points below category average—prospective buyers who prioritize phone streaming for music or media should consider alternatives. Speech in quiet performance is also slightly below average at 2.5/5, a mixed result that may affect understanding in everyday conversation. The Lexie Lumen is best suited for budget-conscious first-time users who prioritize stable, feedback-free amplification over streaming capabilities. However, shoppers in this price range have several higher-performing alternatives available, including the Sony CRE-E10 and Lexie B2 Plus, both of which scored significantly higher in our testing.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.